Literature DB >> 6806467

Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery.

J G De Mey, M Claeys, P M Vanhoutte.   

Abstract

Experiments were designed to investigate the importance of endothelial metabolism of arachidonic acid in the relaxation of isolated arteries caused by acetylcholine, ATP, arachidonic acid itself and thrombin. Rings of canine femoral arteries were mounted for isometric tension recording in organ chambers filled with Krebs-Ringer-bicarbonate solution. Acetylcholine, arachidonic acid, ATP, 15-hydroperoxy-5,8,11,13 eicosatetraenoic acid, thrombin and prostacyclin caused relaxations of control rings made to contract with norepinephrine. Removal of the endothelium abolished the relaxations caused by acetylcholine, ATP, thrombin and 15-hydroperoxy-5,8,11,13 eicosatetraenoic acid, reduced those caused by arachidonic acid, but did not affect the inhibitory effect of prostacyclin. The inhibitory response to arachidonic acid was abolished by indomethacin and 5,8,11,14-eicosatetraynoic acid (ETYA); that to acetylcholine was abolished by mepacrine and reduced by ETYA. The relaxations induced by thrombin and ATP were not affected by these inhibitors. Canine femoral arteries with endothelium, but not de-endothelialized preparations, transformed part of exogenously added [14C] arachidonic acid to prostaglandins (6-oxo-prostaglandin (F1 alpha) and a hydroxy derivative. The formation of prostanoids was inhibited by indomethacin, ETYA and 15-hydroperoxy-5, 8,11,13 eicosatetraenoic acid and that of hydroxy derivative by ETYA. These results suggest that the endothelial cells of canine femoral arteries initiate relaxation of the vascular smooth muscle cells of the media by: 1) producing prostacyclin, when exposed to arachidonic acid; 2) producing a lipoxygenase product, when exposed to acetylcholine; and 3) producing a signal of unknown nature, when exposed to thrombin or ATP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806467

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  75 in total

1.  An immunohistochemical study of endothelial cell heterogeneity in the rat: observations in "en face" Häutchen preparations.

Authors:  A Tomlinson; H Van Vlijmen; A Loesch; G Burnstock
Journal:  Cell Tissue Res       Date:  1991-01       Impact factor: 5.249

2.  The inhibition of release of endothelium-derived relaxant factor by manoalide, a potent inhibitor of phospholipase A2.

Authors:  C J Long; H M Sarau; B A Berkowitz
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

3.  Mechanisms of coronary vasodilatation produced by ATP in guinea-pig isolated perfused heart.

Authors:  I P Brown; C I Thompson; F L Belloni
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

4.  Identification of arginine as a precursor of endothelium-derived relaxing factor.

Authors:  I Sakuma; D J Stuehr; S S Gross; C Nathan; R Levi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  The role of prostaglandins in the endothelium-mediated vasodilatory response to hypoxia.

Authors:  R Busse; U Förstermann; H Matsuda; U Pohl
Journal:  Pflugers Arch       Date:  1984-05       Impact factor: 3.657

6.  Vascular actions of thrombin receptor-derived polypeptides: structure-activity profiles for contractile and relaxant effects in rat aorta.

Authors:  A A Laniyonu; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

7.  Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.

Authors:  A A Quyyumi; N Dakak; N P Andrews; S Husain; S Arora; D M Gilligan; J A Panza; R O Cannon
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  B2 kinin receptor activation is the predominant mechanism by which trypsin mediates endothelium-dependent relaxation in bovine coronary arteries.

Authors:  Grant R Drummond; Stavros Selemidis; Thomas M Cocks
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-06       Impact factor: 3.000

Review 9.  Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease.

Authors:  Ralf Köhler; Brajesh P Kaistha; Heike Wulff
Journal:  Expert Opin Ther Targets       Date:  2010-02       Impact factor: 6.902

Review 10.  Inducible endothelium-derived hyperpolarizing factor: role of the 15-lipoxygenase-EDHF pathway.

Authors:  William B Campbell; Kathryn M Gauthier
Journal:  J Cardiovasc Pharmacol       Date:  2013-03       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.